20th Annual Research Grant Symposium in Louisville anchors month of activities as Foundation awards record $650,000 to advance brain aneurysm research
HANOVER, Mass., Sept. 1, 2026 /PRNewswire/ — The Brain Aneurysm Foundation (BAF), the leading advocacy organization supporting education, research and policy to transform the treatment of brain aneurysms, will mark Brain Aneurysm Awareness Month this September with a broad range of activities across the country, led by its 20th Annual Research Grant Symposium in Louisville, Kentucky, and extending to community events, public awareness initiatives and advocacy efforts nationwide.
On September 17, BAF will bring together leading brain aneurysm researchers from across the United States and Canada for its annual scientific symposium and Research Grant Awards Dinner. This year, the Foundation is awarding a record $650,000 to support 18 research projects spanning genetics, artificial intelligence, diagnostics, imaging and new treatment strategies. Since launching its research grant program in 2007, BAF has invested more than $7 million to advance understanding of how brain aneurysms form and rupture and support new approaches to detection, risk assessment and treatment.
“Brain Aneurysm Awareness Month brings together every part of our mission, from researchers working to change what is possible and clinicians caring for patients, to survivors and families advocating for greater awareness and communities across the country raising funds to support continued progress,” said Christine Buckley, Executive Director of the Brain Aneurysm Foundation. “Our goal is to translate greater awareness into earlier detection, more research, better treatments and, ultimately, fewer lives lost or permanently changed by brain aneurysm rupture.”
An estimated one in 50 people in the United States is living with an unruptured brain aneurysm, and approximately 30,000 Americans suffer a rupture each year. Of those who survive a rupture, more than 70 percent will suffer long-term neurologic challenges.
The month also reflects BAF’s longstanding leadership in bringing greater national attention to brain aneurysms. Beginning more than 15 years ago, the Foundation led a multi-year advocacy effort that resulted in U.S. Senate recognition of September as National Brain Aneurysm Awareness Month. BAF has since continued working with policymakers across the country to increase federal funding for brain aneurysm research, including the bipartisan bill known as Ellie’s Law, which aims to provide additional funds to the National Institutes of Health.
“Few organizations have had a more consequential impact on the brain aneurysm field than the Brain Aneurysm Foundation,” said Walter Koroshetz, M.D., a leading neurologist and neuroscientist and former director of the National Institute of Neurological Disorders and Stroke. “Promising early research funded by the BAF has often led to larger NIH grants, and the organization has been instrumental in bringing together investigators and clinicians from leading institutions, educating patients and medical professionals, and giving survivors and families a national voice. There simply is no other organization that brings these pieces together at this scale, and that leadership has been instrumental in moving the field forward.”
Throughout September, BAF will bring that mission to communities across the country through activities including:
The BAF works throughout the year to increase understanding of brain aneurysm warning signs and risk factors, encourage early detection among those at increased risk, advocate for greater federal research funding, and provide education and support to individuals and families affected by the disease.
About the Brain Aneurysm Foundation
The Brain Aneurysm Foundation (BAF) is the leading advocacy organization supporting education, research, and policy to transform the treatment of brain aneurysms, and is the largest private funder of brain aneurysm research. Through its strategic grant program, BAF fuels breakthroughs in early detection, prevention, treatment, and technology, advancing the standard of care and improving outcomes for patients. To learn more, visit bafound.org.
Media Contact:
Lynn Nuttall
Director of Marketing and Communications
Brain Aneurysm Foundation
781-826-5556 x 208
lynn@bafound.org
SOURCE Brain Aneurysm Foundation
Vancouver, British Columbia--(Newsfile Corp. - September 1, 2026) - Apptly Health Technologies Corp. (CSE: APPT)…
Former Epic AI executive joins PartsSource as company expands investment in AI, data and healthcare…
PLEASANTON, Calif., Sept. 1, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva Falcon Safety,…
eCential Robotics platform to join Enovis' enabling technology portfolio.GRENOBLE, France and FRANKLIN, Tenn., Sept. 1,…
Current CFO, Lisa Wolf named President and COO, assuming expanded executive and operational leadership. Jared…
Q3 2026 study finds human infrastructure, transaction authority and embedded capital are emerging as new…